Shir GrunebaumJun 3, 20224 minThe Argus Trial: Just Another Case of Canadians Waiting for Access to Clinical TrialsEarlier this week, Epygenix Therapeutics shared that the first Canadian participant was dosed in their latest clinical trial
Shir GrunebaumMay 13, 20224 minOutlining Values for Patient Registry Development Patient registries are an increasingly important medium in the rare disease research and development environment.
Faisal Ali MohamedMay 6, 20223 minIncreased Efficacy of CAR-T Treatment on Solid TumorsChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant efficacy against certain blood cancers such as acute...
Wouter BoonApr 15, 20222 minOrphan Drug Designation for an Academia-Driven Pharma ProjectJust last month, the European Medicines Agency (EMA) granted an orphan drug designation for a treatment against pyridoxal...